Cargando…

Highly variable pharmacokinetics of dexmedetomidine during intensive care: a case report

INTRODUCTION: Dexmedetomidine is a selective and potent alpha2-adrenoceptor agonist licensed for use in the sedation of patients initially ventilated in intensive care units at a maximum dose rate of 0.7 μg/kg/h administered for up to 24 hours. Higher dose rates and longer infusion periods are somet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iirola, Timo, Laitio, Ruut, Kentala, Erkki, Aantaa, Riku, Kurvinen, Juha-Pekka, Scheinin, Mika, Olkkola, Klaus T
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Case report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2848065/ https://www.ncbi.nlm.nih.gov/pubmed/20184754 http://dx.doi.org/10.1186/1752-1947-4-73

Ejemplares similares

Pharmacokinetics of prolonged infusion of high-dose dexmedetomidine in critically ill patients
por: Iirola, Timo, et al.
Publicado: (2011)

Pharmacokinetics of long-lasting, high-dose dexmedetomidine infusions in critically ill patients
por: Iirola, T, et al.
Publicado: (2011)

Renal effects of dexmedetomidine during coronary artery bypass surgery: a randomized placebo-controlled study
por: Leino, Kari, et al.
Publicado: (2011)

Predictive equations over-estimate the resting energy expenditure in amyotrophic lateral sclerosis patients who are dependent on invasive ventilation support
por: Siirala, Waltteri, et al.
Publicado: (2010)

Is the effect of non-invasive ventilation on survival in amyotrophic lateral sclerosis age-dependent?
por: Siirala, Waltteri, et al.
Publicado: (2013)

Using respiratory rate and thoracic movement to assess respiratory insufficiency in amyotrophic lateral sclerosis: a preliminary study
por: Siirala, Waltteri, et al.
Publicado: (2012)

Alterations in heart rate variability in patients with peripheral arterial disease requiring surgical revascularization have limited association with postoperative major adverse cardiovascular and cerebrovascular events
por: Utriainen, Karri T., et al.
Publicado: (2018)

Decreased Thalamic Activity Is a Correlate for Disconnectedness during Anesthesia with Propofol, Dexmedetomidine and Sevoflurane But Not S-Ketamine
por: Kantonen, Oskari, et al.
Publicado: (2023)

Population Modelling of Dexmedetomidine Pharmacokinetics and Haemodynamic Effects After Intravenous and Subcutaneous Administration
por: Ashraf, Muhammad W., et al.
Publicado: (2020)

Circulating oxylipin and bile acid profiles of dexmedetomidine, propofol, sevoflurane, and S-ketamine: a randomised controlled trial using tandem mass spectrometry
por: Nummela, Aleksi, et al.
Publicado: (2022)

Traumatic brain injury patient volume and mortality in neurosurgical intensive care units: a Finnish nationwide study
por: Raj, Rahul, et al.
Publicado: (2016)

Predictors of hospital and one-year mortality in intensive care patients with refractory status epilepticus: a population-based study
por: Kantanen, Anne-Mari, et al.
Publicado: (2017)

Pharmacokinetics of dexmedetomidine infusions for patients in the intensive care unit
por: Venn, RM, et al.
Publicado: (2001)

A multinational, drug utilization study to investigate the use of dexmedetomidine (Dexdor®) in clinical practice in the EU
por: Weatherall, Mary, et al.
Publicado: (2017)

Comparison of the prognostic value of early-phase proton magnetic resonance spectroscopy and diffusion tensor imaging with serum neuron-specific enolase at 72 h in comatose survivors of out-of-hospital cardiac arrest—a substudy of the XeHypotheca trial
por: Koskensalo, Kalle, et al.
Publicado: (2022)

Sedation options for the morbidly obese intensive care unit patient: a concise survey and an agenda for development
por: Aantaa, Riku, et al.
Publicado: (2015)

Effect of Inhaled Xenon on Cardiac Function in Comatose Survivors of Out-of-Hospital Cardiac Arrest—A Substudy of the Xenon in Combination With Hypothermia After Cardiac Arrest Trial
por: Saraste, Antti, et al.
Publicado: (2021)

Trends in Mortality after Intensive Care of Patients with Aneurysmal Subarachnoid Hemorrhage in Finland in 2003–2019: A Finnish Intensive Care Consortium study
por: Virta, Jyri J., et al.
Publicado: (2021)

Trends in mortality after intensive care of patients with traumatic brain injury in Finland from 2003 to 2019: a Finnish Intensive Care Consortium study
por: Luostarinen, Teemu, et al.
Publicado: (2021)

External validation of the NeuroImaging Radiological Interpretation System and Helsinki computed tomography score for mortality prediction in patients with traumatic brain injury treated in the intensive care unit: a Finnish intensive care consortium study
por: Vehviläinen, Juho, et al.
Publicado: (2022)

Early thrombocytopenia is associated with an increased risk of mortality in patients with traumatic brain injury treated in the intensive care unit: a Finnish Intensive Care Consortium study
por: Lillemäe, Kadri, et al.
Publicado: (2022)

Is advanced life support better than basic life support in prehospital care? A systematic review
por: Ryynänen, Olli-Pekka, et al.
Publicado: (2010)

Clinical Pharmacokinetics and Pharmacodynamics of Dexmedetomidine
por: Weerink, Maud A. S., et al.
Publicado: (2017)

One-year healthcare costs of patients with spontaneous intracerebral hemorrhage treated in the intensive care unit
por: Smeds, Marika, et al.
Publicado: (2022)

Psychotropic medication use among patients with a traumatic brain injury treated in the intensive care unit: a multi-centre observational study
por: Vehviläinen, Juho, et al.
Publicado: (2021)

Acute pain intensity monitoring with the classification of multiple physiological parameters
por: Jiang, Mingzhe, et al.
Publicado: (2018)

Temporal Trends in Healthcare Costs and Outcome Following ICU Admission After Traumatic Brain Injury
por: Raj, Rahul, et al.
Publicado: (2018)

Enantiospecific pharmacokinetics of intravenous dexmedetomidine in beagles
por: Levionnois, Olivier Louis, et al.
Publicado: (2022)

Pooled Population Pharmacokinetic Analysis for Exploring Ciprofloxacin Pharmacokinetic Variability in Intensive Care Patients
por: Guo, Tingjie, et al.
Publicado: (2022)

The influence of dexmedetomidine and propofol on circulating cytokine levels in healthy subjects
por: Kallioinen, Minna, et al.
Publicado: (2019)

Sedation with dexmedetomidine in the intensive care setting
por: Gerlach, Anthony T, et al.
Publicado: (2011)

Premedication with intranasal dexmedetomidine decreases barbiturate requirement in pediatric patients sedated for magnetic resonance imaging: a retrospective study
por: Uusalo, Panu, et al.
Publicado: (2019)

Effect of xenon on brain injury, neurological outcome, and survival in patients after aneurysmal subarachnoid hemorrhage—study protocol for a randomized clinical trial
por: Laaksonen, Mikael, et al.
Publicado: (2023)

Covariates of intravenous paracetamol pharmacokinetics in adults
por: Allegaert, Karel, et al.
Publicado: (2014)

Population Pharmacokinetics of Dexmedetomidine in Critically Ill Patients
por: Välitalo, Pyry Antti, et al.
Publicado: (2013)

Pharmacokinetics of dexmedetomidine during analgosedation in ICU patients
por: Smuszkiewicz, Piotr, et al.
Publicado: (2017)

Pharmacokinetics of Intranasally Administered Dexmedetomidine in Chinese Children
por: Wang, Cheng-Yu, et al.
Publicado: (2019)

Dexmedetomidine Induced Polyuria in the Intensive Care Unit
por: Uddin, Mohammed M., et al.
Publicado: (2021)

Sedation in non-invasive ventilation: do we know what to do (and why)?
por: Longrois, Dan, et al.
Publicado: (2014)

Transfusion strategies in bleeding critically ill adults: A clinical practice guideline from the European Society of Intensive Care Medicine: Endorsement by the Scandinavian Society of Anaesthesiology and Intensive Care Medicine
por: Møller, Morten Hylander, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b2m4hnrsap1aidldpl30f2ms7m